Octreotide + Lisinopril Interaction
Moderateinteraction on record
Description
Lisinopril: bioavailability may be increased, monitor patient's blood pressure and adjust dose of lisinopril if needed ( 7 ). Lisinopril Clinical Impact: Concomitant administration of MYCAPSSA increases lisinopril bioavailability [see Clinical Pharmacology (12.3) ] . Intervention: Monitor patient's blood pressure and adjust the dosage of lisinopril if needed.
Source: FDA drug label - octreotide